Millennium Management
DYN icon

Millennium Management’s Dyne Therapeutics DYN Stock Holding History

Millennium Management’s Portfolio DYN Stock Details DYN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.87M Sell
158,548
-745,841
-82% -$12.9M ﹤0.01% 3513
2025
Q4 		$17.7M Buy
904,389
+490,449
+118% +$9.29M 0.01% 1697
2025
Q3 		$5.24M Buy
413,940
+271,221
+190% +$3.09M ﹤0.01% 3103
2025
Q2 		$1.36M Buy
142,719
+64,540
+83% +$711K ﹤0.01% 4195
2025
Q1 		$818K Buy
78,179
+40,643
+108% +$581K ﹤0.01% 4499
2024
Q4 		$884K Buy
37,536
+31,545
+527% +$933K ﹤0.01% 4299
2024
Q3 		$215K Buy
+5,991
New +$238K ﹤0.01% 5409
2024
Q2 		– Sell
-18,011
Closed -$511K – 6016
2024
Q1 		$511K Sell
18,011
-370,079
-95% -$8.37M ﹤0.01% 4801
2023
Q4 		$5.16M Buy
+388,090
New +$3.79M ﹤0.01% 2764
2023
Q2 		– Sell
-190,363
Closed -$2.19M – 6211
2023
Q1 		$2.19M Sell
190,363
-63,747
-25% -$828K ﹤0.01% 3356
2022
Q4 		$2.94M Buy
254,110
+172,159
+210% +$1.99M ﹤0.01% 3230
2022
Q3 		$1.04M Buy
+81,951
New +$940K ﹤0.01% 4308
2021
Q1 		– Sell
-38,590
Closed -$810K – 6042
2020
Q4 		$810K Sell
38,590
-155,475
-80% -$3.08M ﹤0.01% 3868
2020
Q3 		$3.92K Buy
+194,065
New +$4.26M ﹤0.01% 2058

Other funds holding DYN

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
FIS
FCPM III Services Naarden, Netherlands $722M AUM 73.61% 1-Year Est. Return

Millennium Management's DYN Position: Q1 2026 in Review

Millennium Management reduced its Dyne Therapeutics (DYN) stake by 82% in Q1 2026, selling an estimated $12.9M and leaving 158,548 shares worth $2.87M. The position accounts for ﹤0.01% of the portfolio, ranked #3513.

Millennium Management first reported a position in DYN in Q3 2020 and has held it in 14 quarters since. The position peaked at $17.7M in Q4 2025. 227 funds tracked by Wall St. Rank hold DYN as of Q1 2026.

  • Millennium Management held 158,548 shares of Dyne Therapeutics worth $2.87M as of Q1 2026.
  • Millennium Management sold 745,841 Dyne Therapeutics shares in Q1 2026, an estimated $12.9M.
  • Dyne Therapeutics made up ﹤0.01% of Millennium Management's portfolio in Q1 2026, its #3513 holding.
  • Millennium Management first reported a position in Dyne Therapeutics in Q3 2020 and has held it in 14 quarters since.
  • Millennium Management's Dyne Therapeutics position peaked at $17.7M in Q4 2025.
  • 227 funds tracked by Wall St. Rank held Dyne Therapeutics as of Q1 2026.

Based on Millennium Management's 13F filing for Q1 2026, filed 15 May 2026.